Saudi healthcare is being privatised.
The audit, tax, and compliance bar is rising with it.
The Health Sector Transformation Programme is reshaping how care is delivered, paid for, and regulated in the Kingdom. Private clinics, hospital groups, pharmacy chains, medical labs, and home healthcare providers are scaling alongside that transformation. AlHisabat audits, advises, and tax-structures Saudi private healthcare operators so the financial discipline keeps pace with insurance receivables management, drug inventory complexity, clinical Saudization, and an MoH and CBAHI compliance regime that is unforgiving.
Private healthcare is now a national priority.
Insurance receivables are the operational reality.
The Health Sector Transformation Programme has separated the payer, provider, and regulator functions of the public healthcare system. Mandatory health insurance has expanded the addressable private-pay market. CCHI now governs the insurance side, MoH and CBAHI the provider side, and SFDA the pharmaceutical and medical-device side. Private hospital groups, multi-specialty clinic chains, single-specialty centres, pharmacy networks, and medical labs have all been scaling into this environment.
For mid-market Saudi healthcare operators, the financial discipline required is closer to a sophisticated trading business than a clinical practice. Insurance receivables management - claims submission, rejection handling, resubmission, and collections - is where margin lives or dies. Drug inventory carries expiry risk, controlled-substance compliance, and SFDA traceability requirements that require purpose-built process. Clinical Saudization is at thresholds that operations leadership often discovers too late. ZATCA Phase 2 integration touches every consultation, prescription, and procedure invoice. The healthcare operators that scale through this environment are the ones whose finance and revenue-cycle systems are designed for it.
Three patterns repeating across the sector.
Insurance receivables that quietly age into write-offs
Claims are submitted to insurers. Some are paid. Some are rejected. Some are partially paid. The practice files the rejections in a folder titled "for resubmission" and the folder gets bigger every month. Without a disciplined denial-management process, rejected claims age past the resubmission window, become uncollectible, and quietly write off through the bad-debt provision. The cumulative impact across a year is sometimes the difference between a profitable practice and a marginal one.
Drug inventory that expires faster than it sells
Pharmaceutical and surgical-supply inventory carries hard expiry dates, controlled-substance custody requirements, cold-chain integrity rules, and SFDA traceability obligations. Without category-level turnover discipline, inventory ages into expiry write-offs that hit margin directly. SFDA inspections of central pharmacies and outlet stocks are continuous. Findings on traceability or controlled-substance custody have consequences that extend beyond financial penalties.
Clinical Saudization that nobody is tracking until the inspection
Healthcare Saudization applies differentially across clinical and administrative roles, with thresholds that change by activity code and facility type. Recruitment of qualified Saudi nurses, technicians, and licensed practitioners is operationally hard. Multi-site providers find their compliance ratio drifting at the facility level even when the group total looks acceptable. Inspections happen at the facility level. The finding lands at the facility level. The penalty applies group-wide.
Six service lines specifically tuned for healthcare.
Revenue cycle & insurance receivables
Insurance claim submission discipline, denial-management process design, resubmission tracking, ageing analysis by payer and by reason code. The single biggest determinant of financial outcome in private healthcare.
Audit & assurance
IFRS audit with deep familiarity in healthcare specifics - insurance receivables ECL, drug inventory expiry provisioning, contract-asset accounting under capitation arrangements, IFRS 16 lease treatment for clinic and hospital networks.
Drug & supply inventory accounting
Category-level inventory turnover, expiry tracking, controlled-substance custody documentation, cold-chain compliance audits. Stock-take governance that holds up under SFDA inspection.
Zakat, VAT & ZATCA Phase 2
VAT treatment of healthcare services - exempt versus zero-rated, supplies to insurers versus self-pay, pharmaceutical sales. Phase 2 integration audits across hospital information systems and pharmacy POS.
Payroll & clinical Saudization
Multi-facility payroll for clinical workforces, EOSB accruals, occupational hazard classification specific to healthcare. Clinical Saudization tracking per facility integrated into the monthly pack.
Advisory & restructuring
Facility portfolio review, payer-mix optimisation, capacity planning. Pre-opening financial planning for new facilities. Family-business succession planning for founder-led healthcare groups. M&A diligence support when consolidation appears.
ZATCA and SOCPA are the start.
Health regulators decide whether you operate.
Healthcare compliance is multi-axis - tax, audit, ministry-level licensing, insurance regulator, drug authority, and the nationalisation regime. We map every authority that applies and the cadence of compliance across them.
Five KPIs every Saudi private healthcare operator should report monthly.
These are the operational metrics that drive the financial outcome - and the ones lenders, insurers, and acquirers ask about when conversations get serious.
Insurance receivables DSO
Days sales outstanding on insurance receivables, by payer. Anything above 90 days warrants partner-level review of denial management and payer relationships.
Claim rejection rate
First-pass rejection rate by payer, by reason code, by service line. The leading indicator of revenue leakage - and the one operations leadership most often misses.
Drug and supply inventory turnover
Inventory turnover by category and by expiry tier - critical for pharmaceutical and surgical-supply inventory. Slowing turnover in any category is the leading indicator of expiry write-off risk.
Capacity utilisation
Bed occupancy for inpatient facilities, chair or room utilisation for clinic networks, OR utilisation for surgical centres. The single most important driver of facility-level economics.
Clinical Saudization per facility
Saudi national headcount for clinical roles per facility against the applicable Nitaqat threshold. Slipping at facility level has hiring, visa, and licensing consequences immediately.
Three things we always check first.
On every new healthcare engagement the partner runs a short diagnostic on the same three issues. They are the most common sources of regulator finding, restatement, and lender concern in this sector.
Denial-management discipline
Is there a defined process for handling rejections - resubmission timelines, root-cause analysis, payer-level reporting? Without it, claim revenue ages into write-offs every quarter.
Drug inventory provisioning
Is expiry-based provisioning applied consistently, with category-level visibility? And are controlled-substance custody and cold-chain integrity documented in a way that survives an SFDA inspection?
Saudization tracked per facility
Is the Nitaqat ratio measured at group level only, or per facility per activity code? Inspections happen at the facility level - tracking has to match.
Three typical mandates.
The shape of a healthcare engagement varies by facility type and ownership structure. Below are three patterns that recur often enough to be worth describing in advance.
Multi-specialty clinic chain, 8 locations, SAR 110M revenue
Founder-led, growing through new-clinic openings, primarily insurance-pay. Engagement combines a denial-management diagnostic across the payer mix, a multi-facility consolidation rebuild, clinical Saudization tracking integrated per facility, and a Phase 2 integration audit covering hospital information systems and pharmacy POS.
Single-hospital, 80 beds, SAR 200M revenue
Family-owned mid-size hospital, mixed payer base, CBAHI accredited. Engagement focuses on revenue cycle overhaul including claims submission and resubmission discipline, drug and surgical-supply inventory accounting, IFRS audit at lender-grade quality, and a capacity utilisation diagnostic across departments.
Pharmacy chain, 25 outlets plus central warehouse, SAR 240M revenue
Founder-owned, growing footprint, mixed front-shop and prescription revenue. Engagement runs across central-warehouse and outlet inventory accounting with expiry and controlled-substance discipline, multi-outlet consolidation, Phase 2 integration health check, and Saudization tracking per outlet against retail-pharmacy thresholds.
Tell us where you're stuck.
We'll tell you what we'd do first.
Whether the trigger is insurance receivables strain, an SFDA inspection finding, a Saudization issue, a new facility opening, or an upcoming audit - a senior partner will respond within one working day with a short read of your situation and where we'd start.